Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study - Wikidata - wikimedia - TriplyDB

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study

http://www.wikidata.org/entity/Q34686057

about

Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis Right first time!The Use of Bloodstream Infection Mortality to Measure the Impact of Antimicrobial Stewardship Interventions: Assessing the Evidence Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy.Sepsis Patients with First and Second-Hit Infections Show Different Outcomes Depending on the Causative Organism.Utilizing Monte Carlo Simulations to Optimize Institutional Empiric Antipseudomonal Therapy.Pseudomonas aeruginosa Colonization in the Intensive Care Unit: Prevalence, Risk Factors, and Clinical Outcomes.Bloodstream infections in the Intensive Care Unit.The Performance of Direct Disk Diffusion for Community Acquired Bacteremia due to Gram-Negative Bacilli and Its Impact on Physician Treatment Decisions.Drug combination therapy increases successful drug repositioning.Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria.A stepwise introduction of a successful antimicrobial stewardship program. Experience from a tertiary care university hospital in Western, Saudi Arabia Drug repurposing screens and synergistic drug-combinations for infectious diseases.A population genomics approach to exploiting the accessory 'resistome' of Escherichia coli.Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States.Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae?Modeling risk for developing drug resistant bacterial infections in an MDR-naive critically ill population.Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis.Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program.Pseudomonas aeruginosa prevalence, antibiotic resistance and antimicrobial use in Chinese burn wards from 2007 to 2014.Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?Continuous infusion of beta-lactams: a blissful option for the intensive care unit.CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens.Clinical effect of discordance in empirical treatment of cases with urinary tract infection accompanied by bacteremia.30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study.Tristemma hirtum and Five Other Cameroonian Edible Plants with Weak or No Antibacterial Effects Modulate the Activities of Antibiotics against Gram-Negative Multidrug-Resistant Phenotypes.A comparison of the efficacy and safety of intravenous followed by oral delafloxacin with vancomycin plus aztreonam for the treatment of acute bacterial skin and skin structure infections: a phase 3, multinational, double-blind, randomized study.Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients

P2860

Q26751621-B8EE0126-117C-4A91-885D-A88689013C47 Q26783911-5E8EA777-09B7-4711-8F33-E8AEEF916612 Q28067972-8038245C-57FE-4C1E-BB11-1BA20D149675 Q33564316-C79C5FD0-5CDF-47D6-9951-28CBD3C1F564 Q33568677-3E33466A-8549-46E4-B4D8-C98C1EAB824C Q35996888-5D6FA3F1-58AD-4C4A-8D46-B273C1F053C5 Q36355345-9B15E0AC-E753-4DD9-9B56-7D6BA6F0E9B8 Q36620689-D6613D14-82F5-466B-96B4-8F59CA8D7B13 Q36683532-6DF87440-EF3A-462C-83E1-4E90646E106A Q36803212-7A3CF60E-15E5-44B7-BD4C-7100F61CE95F Q36913336-B4204853-2B61-4A39-AF4F-B2086C789AC7 Q36996854-02457F03-0EAE-47DA-AD38-A3D72C3B3344 Q37004251-B48A8426-87F2-49FA-AA93-D7D8A9A8D09A Q37489932-C7C47BCF-D1EA-49B9-9280-76603F177AD8 Q37637620-5EC77A35-321B-4D27-A72D-E3A731E9EF69 Q38158092-222963C0-4F96-4ECB-9561-5C74C8C0A2DD Q38635832-B5961DBB-F57C-48CA-8AF9-346C8D8D7898 Q39446285-011A5638-61CA-4DD5-B31C-A78F0131B145 Q40068450-8D42D4E5-BEDB-4002-A0C2-8BA1B9D4311C Q40117928-DD5592B9-4329-490B-A60F-BE5E92A7B388 Q40612894-99936774-5697-4B02-A18A-00F9FBB6EE86 Q41281692-4F422F9D-9BBD-43F6-9747-CC94251B5DCC Q41935075-8F3F3EEF-3A3B-4137-8CD4-700191894B0E Q42278779-0A31584E-45D4-4A36-830F-D758AFDD40F9 Q42331413-12FC69BB-750E-4FAC-B5D3-659666EFF9B8 Q43776277-8F3768F3-1F6C-4E16-B835-3F0F79B772C1 Q45925882-E4936718-AE35-4B36-BE5F-DA433890E4DB Q47119052-631EDA83-10CF-4AC9-9B43-F1B3A76BCC1A Q54210700-8527FBA4-8069-4884-9B90-7AA9F35F42B9 Q54259788-4FA8B6D2-C238-4817-AC68-F15E3B613083 Q58701649-E76C09B4-9FE5-4F10-9417-CEA32E9B763D

P2860

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study

http://www.wikidata.org/entity/Q34686057

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Multi-drug resistance, inappro ...... : a retrospective cohort study

@ast

Multi-drug resistance, inappro ...... : a retrospective cohort study

@en

Multi-drug resistance, inappro ...... : a retrospective cohort study

@nl

type

label

Multi-drug resistance, inappro ...... : a retrospective cohort study

@ast

Multi-drug resistance, inappro ...... : a retrospective cohort study

@en

Multi-drug resistance, inappro ...... : a retrospective cohort study

@nl

prefLabel

Multi-drug resistance, inappro ...... : a retrospective cohort study

@ast

Multi-drug resistance, inappro ...... : a retrospective cohort study

@en

Multi-drug resistance, inappro ...... : a retrospective cohort study

@nl

P1433

Q34686057-894A4D57-2A20-4CF7-A75B-341FECFD2396

P1476

Q34686057-13D77870-1F83-45CE-9881-51B73076CA19

P2093

Q34686057-795BCDD9-AF1D-489F-B08F-9BB1700374CB

Q34686057-7CCC266C-E685-4D5C-919B-8B71A00C5EBB

Q34686057-9505CD3D-947C-4930-A76E-379D06519E9A

Q34686057-BBD99065-DE11-4FE9-BEE1-5D67934A90AF

P2860

Q34686057-07307A48-A216-4214-84AC-3C8E7C433336

Q34686057-0ECA9A4B-82EF-4ACA-B7E5-C7167C1FFEFC

Q34686057-0F6A0BB5-D9B9-45AD-B979-8EFE1959E06A

Q34686057-30334DDB-2489-4365-AB27-56D9E658B28B

Q34686057-3A3CB004-A8AE-4611-B15C-37E38AD3D946

Q34686057-3C51361C-2869-4278-BB76-A3077DC27C63

Q34686057-41B5D1AF-BE2A-4731-8376-69C9C474846B

Q34686057-4686E864-C334-4CD0-86E4-B5D7BD280224

Q34686057-489FA1A6-B96A-449D-9810-DC01F7562E7E

Q34686057-6184921E-53A3-47DD-9166-A9CC6F0C6723

P2888

Q34686057-56C876E2-E545-4644-A557-DF08B4AC946A

P304

Q34686057-5BC10417-395B-4C11-9584-73F1EB81E9AA

P31

Q34686057-A95AD808-D8C2-4B2E-8124-9A4DC04E7A7D

P356

Q34686057-04C53925-CFA7-4006-BE51-F5E17F32717E

P433

Q34686057-EA7259F0-1EF3-4C1A-B711-70D82F519650

P478

Q34686057-55D5F4D7-72DF-4EF6-9FC7-962DE47F9DAA

P50

Q34686057-053A8AD5-3D82-4235-86E9-F6F34722C35A

P577

Q34686057-1E410682-D435-4AD3-94E4-EA0B632E1D78

P698

Q34686057-682D94B2-64FE-4379-A539-0AA5A57E1466

P921

Q34686057-0DAE685A-192B-4B4F-A924-473F92A34195

Q34686057-7E44FCC7-2D41-436A-8558-DD8937054855

Q34686057-83030728-070A-42DC-9306-579D4E2EE2AE

Q34686057-FEC7B8E3-66C9-483B-9B38-815111F6CAA6

P932

Q34686057-E4D208DB-EDE3-489D-846D-EBDA6FF8BF71

P356

PREACCEPT-6556009101270526

P1433

P1476

Multi-drug resistance, inappro ...... : a retrospective cohort study

@en

P2093

Andrew F Shorr

http://www.w3.org/2001/XMLSchema#string

Cristina Vazquez-Guillamet

http://www.w3.org/2001/XMLSchema#string

Marya D Zilberberg

http://www.w3.org/2001/XMLSchema#string

Scott T Micek

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

APACHE II: a severity of disease classification system

Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Nephrotoxicity of intravenous colistin: a prospective evaluation.

P2888

preaccept-6556009101270526

P304

596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/PREACCEPT-6556009101270526

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25412897

http://www.w3.org/2001/XMLSchema#string

P921

antibiotic resistance

Gram-negative bacteria

multiple drug resistance

P932

4264255

http://www.w3.org/2001/XMLSchema#string